Investing.com -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)股价下跌1.5%，此前美国上诉法院维持了先前的裁决，实际上驳回了暂停销售其药物Eylea仿制药的申请。法院认为Regeneron在专利案中的其余论点"缺乏说服力"。

The U.S. stock market's artificial intelligence boom is facing a setback. On March 3, Nvidia, a leading AI stock, dropped 8.69%, dragging the Nasdaq down 2.64%. The Dow Jones and S&P 500 also fell, by ...